Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 419 across all filing types
Latest filing 2022-01-16 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
北京市康达律师事务所关于北京颖泰嘉和生物科技股份有限公司2022年第一次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, and voting procedures and results of the 2022 first extraordinary general meeting (临时股东大会) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the legality and validity of the meeting's procedures and resolutions. The document is not a report of financial results, audit, or management discussion, but a legal opinion on the shareholder meeting process and voting outcomes. This type of document corresponds to Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the meeting procedures. The document length is over 6000 characters and contains detailed voting results, not just an announcement of a report publication or a brief notice. Therefore, the correct classification is DVA with high confidence.
2022-01-16 Chinese
2022年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2022 first extraordinary shareholders meeting of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the meeting date, attendance, agenda items, voting results on various amendments to company rules and systems, and legal opinions confirming the meeting's compliance. The content is focused on the official voting results and resolutions passed at a shareholders meeting, not the meeting materials or presentations themselves. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is over 6000 characters and contains detailed voting results, so it is not a brief announcement or a report publication notice. Therefore, the classification is DVA with high confidence.
2022-01-16 Chinese
关于全资子公司临时停产的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the temporary suspension of production at its wholly-owned subsidiaries due to a government-mandated safety shutdown related to the Beijing Winter Olympics. It discusses operational impacts, mitigation measures, and risk warnings. There are no financial statements, no detailed financial data, no mention of annual or quarterly reports, nor any regulatory certifications or voting results. The document is a regulatory announcement informing investors about a significant operational event affecting the company. It is not a financial report, earnings release, or management discussion. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2022-01-04 Chinese
西南证券股份有限公司关于北京颖泰嘉和生物科技股份有限公司关联交易的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from Southwest Securities Co., Ltd. regarding related party transactions of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It discusses the review and approval process of new related party transactions for the year 2022, including details on transaction amounts, related parties, board meeting approvals, and fairness assessments. The document is a formal opinion or verification report by the sponsor institution rather than a full financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a proxy solicitation or management report. It is a regulatory compliance-related document focused on related party transaction review and approval, fitting best under Regulatory Filings (RNS) as a miscellaneous regulatory compliance filing that does not fit other categories.
2021-12-29 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is issued by the company's board. It details the internal rules, procedures, and controls regarding the company's external guarantees, including approval processes, risk control, disclosure requirements, and responsibilities. It references company laws, securities laws, and stock exchange listing rules, indicating it is a governance-related document. There is no financial data, earnings information, or audit results presented. The document is a detailed policy or governance framework rather than a report or announcement of financial results or voting outcomes. Therefore, it fits best under Governance Information (CGR). The document length is 4682 characters, which is sufficient for a detailed governance report rather than a brief announcement.
2021-12-29 Chinese
关联交易决策制度
Governance Information Classification · 95% confidence The document is titled '关联交易决策制度' which translates to 'Related Party Transaction Decision System'. It is a detailed policy document issued by the company's board, outlining the principles, definitions, procedures, and disclosure requirements for related party transactions. It includes references to relevant laws, company bylaws, and regulatory requirements. The document is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under governance information. The document length is 7661 characters, indicating it is a full policy document rather than a brief announcement. Therefore, the most appropriate classification is Governance Information (CGR).
2021-12-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.